Bupropion Sustained-Release Tablets (Smoking Deterrent) and Conjugated estrogens and medroxyprogesterone
Determining the interaction of Bupropion Sustained-Release Tablets (Smoking Deterrent) and Conjugated estrogens and medroxyprogesterone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: conjugated estrogens / medroxyprogesterone
Brand name: Premphase, Prempro
Synonyms: Estrogens (Conjugated/Equine) and Medroxyprogesterone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated estrogens and medroxyprogesterone Oral
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated Estrogens Injection
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated estrogens Intravenous
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated estrogens synthetic a
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated estrogens synthetic b
- Bupropion Sustained-Release Tablets (Smoking Deterrent)-Conjugated Estrogens Tablets
- Conjugated estrogens and medroxyprogesterone-Bupropion Tablets
- Conjugated estrogens and medroxyprogesterone-Bupropion Tablets and Sustained-Release Tablets
- Conjugated estrogens and medroxyprogesterone-Burapren Injection
- Conjugated estrogens and medroxyprogesterone-Burn-O-Jel Topical application
- Conjugated estrogens and medroxyprogesterone-Burnamycin Topical application
- Conjugated estrogens and medroxyprogesterone-Burosumab